Literature DB >> 18080003

In vitro microscopic imaging of enhanced thrombolysis with 120-kHz ultrasound in a human clot model.

Jason Y Cheng1, George J Shaw, Christy K Holland.   

Abstract

Substantial enhancement of recombinant tissue plasminogen activator (rt-PA) thrombolysis can be achieved with ultrasound, suggesting its use as an adjunctive treatment in thrombolytic therapy for stroke. A microscopic visualization method was used to measure the lysis of human whole-blood clots treated with human fresh frozen plasma (HFFP), rt-PA, and 120-kHz ultrasound for 30 min at T = 37 ° C. The clot-plasma interface was imaged using an inverted optical microscope and the thrombolytic front analyzed as a function of time. Ultrasound treatment significantly enhanced the mean lytic rate from 0.5 to 3.4 μm/min (a 580% change) compared with rt-PA treatment alone.

Entities:  

Year:  2005        PMID: 18080003      PMCID: PMC2137158          DOI: 10.1121/1.1815039

Source DB:  PubMed          Journal:  Acoust Res Lett Online        ISSN: 1529-7853


  10 in total

1.  Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed: dynamic and structural approaches by confocal microscopy.

Authors:  J P Collet; D Park; C Lesty; J Soria; C Soria; G Montalescot; J W Weisel
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-05       Impact factor: 8.311

2.  Acceleration of fibrinolysis by high-frequency ultrasound: the contribution of acoustic streaming and temperature rise.

Authors:  D V Sakharov; R T Hekkenberg; D C Rijken
Journal:  Thromb Res       Date:  2000-11-15       Impact factor: 3.944

3.  Cavitational mechanisms in ultrasound-accelerated thrombolysis at 1 MHz.

Authors:  E C Everbach; C W Francis
Journal:  Ultrasound Med Biol       Date:  2000-09       Impact factor: 2.998

4.  Ultrasound accelerates transport of recombinant tissue plasminogen activator into clots.

Authors:  C W Francis; A Blinc; S Lee; C Cox
Journal:  Ultrasound Med Biol       Date:  1995       Impact factor: 2.998

5.  A structural and dynamic investigation of the facilitating effect of glycoprotein IIb/IIIa inhibitors in dissolving platelet-rich clots.

Authors:  J Ph Collet; G Montalescot; C Lesty; J W Weisel
Journal:  Circ Res       Date:  2002-03-08       Impact factor: 17.367

6.  Transport phenomena and clot dissolving therapy: an experimental investigation of diffusion-controlled and permeation-enhanced fibrinolysis.

Authors:  J H Wu; K Siddiqui; S L Diamond
Journal:  Thromb Haemost       Date:  1994-07       Impact factor: 5.249

7.  Pharmacokinetics and haemostatic status during consecutive infusions of recombinant tissue-type plasminogen activator in patients with acute myocardial infarction.

Authors:  E Seifried; P Tanswell; D Ellbrück; W Haerer; A Schmidt
Journal:  Thromb Haemost       Date:  1989-06-30       Impact factor: 5.249

8.  Low-frequency, low-intensity ultrasound accelerates thrombolysis through the skull.

Authors:  S Behrens; M Daffertshofer; D Spiegel; M Hennerici
Journal:  Ultrasound Med Biol       Date:  1999-02       Impact factor: 2.998

Review 9.  Ultrasound in the treatment of ischaemic stroke.

Authors:  Michael Daffertshofer; Michael Hennerici
Journal:  Lancet Neurol       Date:  2003-05       Impact factor: 44.182

Review 10.  Pharmacokinetics and hepatic catabolism of tissue-type plasminogen activator.

Authors:  P Tanswell; E Seifried; E Stang; J Krause
Journal:  Arzneimittelforschung       Date:  1991-12
  10 in total
  17 in total

1.  Combination treatment with rt-PA is more effective than rt-PA alone in an in vitro human clot model.

Authors:  Jason M Meunier; Christy K Holland; Tyrone M Porter; Christopher J Lindsell; George J Shaw
Journal:  Curr Neurovasc Res       Date:  2011-11       Impact factor: 1.990

2.  Correlation of cavitation with ultrasound enhancement of thrombolysis.

Authors:  Saurabh Datta; Constantin-C Coussios; Louis E McAdory; Jun Tan; Tyrone Porter; Gabrielle De Courten-Myers; Christy K Holland
Journal:  Ultrasound Med Biol       Date:  2006-08       Impact factor: 2.998

Review 3.  Sonothrombolysis.

Authors:  Kenneth B Bader; Guillaume Bouchoux; Christy K Holland
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

4.  Cavitation thresholds of contrast agents in an in vitro human clot model exposed to 120-kHz ultrasound.

Authors:  Matthew J Gruber; Kenneth B Bader; Christy K Holland
Journal:  J Acoust Soc Am       Date:  2014-02       Impact factor: 1.840

5.  In vitro thrombolytic efficacy of echogenic liposomes loaded with tissue plasminogen activator and octafluoropropane gas.

Authors:  Himanshu Shekhar; Kenneth B Bader; Shenwen Huang; Tao Peng; Shaoling Huang; David D McPherson; Christy K Holland
Journal:  Phys Med Biol       Date:  2016-12-21       Impact factor: 3.609

6.  Making the right choice: optimizing rt-PA and eptifibatide lysis, an in vitro study.

Authors:  George J Shaw; Jason M Meunier; Christopher J Lindsell; Arthur M Pancioli; Christy K Holland
Journal:  Thromb Res       Date:  2010-09-01       Impact factor: 3.944

7.  Shaken and stirred: mechanisms of ultrasound-enhanced thrombolysis.

Authors:  Kenneth B Bader; Matthew J Gruber; Christy K Holland
Journal:  Ultrasound Med Biol       Date:  2014-11-15       Impact factor: 2.998

8.  Ultrasound-enhanced thrombolysis with tPA-loaded echogenic liposomes.

Authors:  George J Shaw; Jason M Meunier; Shao-Ling Huang; Christopher J Lindsell; David D McPherson; Christy K Holland
Journal:  Thromb Res       Date:  2009-02-13       Impact factor: 3.944

9.  Individual lytic efficacy of recombinant tissue plasminogen activator in an in vitro human clot model: rate of "nonresponse".

Authors:  Jason M Meunier; Evan Wenker; Christopher J Lindsell; George J Shaw
Journal:  Acad Emerg Med       Date:  2013-05       Impact factor: 3.451

10.  Effect of low frequency ultrasound on combined rt-PA and eptifibatide thrombolysis in human clots.

Authors:  Jason M Meunier; Christy K Holland; Arthur M Pancioli; Christopher J Lindsell; George J Shaw
Journal:  Thromb Res       Date:  2008-07-10       Impact factor: 3.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.